Thus, further studies for DEFB1 and other molecules of the innate immune system may lead to the identification of novel genetic determinants in the development of COPD, which may lead to better understanding of COPD pathophysiology and new opportunities for prevention and treatment. This evidence concerns the gene DEFB1 and chronic obstructive pulmonary disease.